Dimensional Fund Advisors
ENTA icon

Dimensional Fund Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Dimensional Fund Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.57M Sell
203,252
-8,362
-4% -$112K ﹤0.01% 2651
2025
Q4 		$3.34M Sell
211,614
-58,454
-22% -$742K ﹤0.01% 2630
2025
Q3 		$3.24M Sell
270,068
-7,572
-3% -$60.5K ﹤0.01% 2649
2025
Q2 		$2.1M Sell
277,640
-4,662
-2% -$28K ﹤0.01% 2750
2025
Q1 		$1.56M Sell
282,302
-14,804
-5% -$91.4K ﹤0.01% 2775
2024
Q4 		$1.71M Buy
297,106
+102,646
+53% +$984K ﹤0.01% 2827
2024
Q3 		$2.01M Buy
194,460
+65,398
+51% +$855K ﹤0.01% 2779
2024
Q2 		$1.67M Sell
129,062
-60,194
-32% -$813K ﹤0.01% 2802
2024
Q1 		$3.3M Buy
189,256
+9,693
+5% +$128K ﹤0.01% 2663
2023
Q4 		$1.69M Sell
179,563
-17,190
-9% -$160K ﹤0.01% 2820
2023
Q3 		$2.2M Sell
196,753
-248,689
-56% -$4.01M ﹤0.01% 2753
2023
Q2 		$9.53M Sell
445,442
-93,247
-17% -$2.75M ﹤0.01% 2279
2023
Q1 		$21.8M Sell
538,689
-4,877
-0.9% -$233K 0.01% 1861
2022
Q4 		$25.3K Buy
543,566
+33,688
+7% +$1.54M 0.01% 1740
2022
Q3 		$26.4M Sell
509,878
-13,831
-3% -$808K 0.01% 1664
2022
Q2 		$24.8M Sell
523,709
-69,811
-12% -$3.79M 0.01% 1741
2022
Q1 		$42.2M Sell
593,520
-8,218
-1% -$535K 0.01% 1541
2021
Q4 		$45M Sell
601,738
-9,128
-1% -$716K 0.01% 1486
2021
Q3 		$34.7M Sell
610,866
-33,922
-5% -$1.68M 0.01% 1684
2021
Q2 		$28.4M Buy
644,788
+57,292
+10% +$2.81M 0.01% 1876
2021
Q1 		$29M Sell
587,496
-83,725
-12% -$4.18M 0.01% 1828
2020
Q4 		$28.3M Sell
671,221
-28,792
-4% -$1.27M 0.01% 1798
2020
Q3 		$32M Sell
700,013
-16,825
-2% -$815K 0.01% 1550
2020
Q2 		$36M Buy
716,838
+1,335
+0.2% +$69.1K 0.02% 1480
2020
Q1 		$36.8M Buy
715,503
+14,712
+2% +$784K 0.02% 1302
2019
Q4 		$43.3M Buy
700,791
+32,100
+5% +$1.99M 0.02% 1551
2019
Q3 		$40.2M Buy
668,691
+42,633
+7% +$3.17M 0.02% 1575
2019
Q2 		$52.8M Sell
626,058
-2,955
-0.5% -$266K 0.02% 1373
2019
Q1 		$60.1M Buy
629,013
+5,383
+0.9% +$483K 0.02% 1198
2018
Q4 		$44.2M Buy
623,630
+19,624
+3% +$1.5M 0.02% 1389
2018
Q3 		$51.6M Buy
604,006
+10,159
+2% +$1.02M 0.02% 1424
2018
Q2 		$68.8M Buy
593,847
+537
+0.1% +$53.6K 0.03% 1046
2018
Q1 		$48M Buy
593,310
+32,640
+6% +$2.51M 0.02% 1388
2017
Q4 		$32.9M Sell
560,670
-1,724
-0.3% -$86.3K 0.01% 1752
2017
Q3 		$26.3M Buy
562,394
+7,617
+1% +$306K 0.01% 1883
2017
Q2 		$20M Buy
554,777
+141,688
+34% +$4.53M 0.01% 2028
2017
Q1 		$12.7M Buy
413,089
+233,265
+130% +$7.26M 0.01% 2221
2016
Q4 		$6.02M Buy
179,824
+152,511
+558% +$4.37M ﹤0.01% 2491
2016
Q3 		$726K Buy
27,313
+1,700
+7% +$39.5K ﹤0.01% 2996
2016
Q2 		$565K Hold
25,613
– – ﹤0.01% 3030
2016
Q1 		$752K Buy
25,613
+100
+0.4% +$2.78K ﹤0.01% 2978
2015
Q4 		$843K Buy
25,513
+300
+1% +$9.78K ﹤0.01% 2994
2015
Q3 		$910K Buy
25,213
+1,000
+4% +$42.9K ﹤0.01% 3007
2015
Q2 		$1.09M Buy
24,213
+13,012
+116% +$506K ﹤0.01% 3008
2015
Q1 		$343K Buy
+11,201
New +$436K ﹤0.01% 3162

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors's ENTA Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Enanta Pharmaceuticals (ENTA) stake by 4% in Q1 2026, selling an estimated $112K and leaving 203,252 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Dimensional Fund Advisors first reported a position in ENTA in Q1 2015 and has held it in 45 quarters since. The position peaked at $68.8M in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Dimensional Fund Advisors held 203,252 shares of Enanta Pharmaceuticals worth $2.57M as of Q1 2026.
  • Dimensional Fund Advisors sold 8,362 Enanta Pharmaceuticals shares in Q1 2026, an estimated $112K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2651 holding.
  • Dimensional Fund Advisors first reported a position in Enanta Pharmaceuticals in Q1 2015 and has held it in 45 quarters since.
  • Dimensional Fund Advisors's Enanta Pharmaceuticals position peaked at $68.8M in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.